IP Verse

Glaxosmithkline Biologicals S.a. competitive analysis

Latest oppositions filed by Glaxosmithkline Biologicals S.a.

Explore patent oppositions filed by Glaxosmithkline Biologicals S.a. against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 10, 2026
Patent NumberTitleApplicantOpposition Date
EP2558116
Agent For Locally Treating Cervical DysplasiasCHARIT UNIVERSITTSMEDIZIN BERLINDec 21, 2017
EP2240595
Glycosylated Protein Expression In ProkaryotesCORNELL RESEARCH FOUNDATIONSep 16, 2016
EP2601933
Hydrophilic Filtration During Manufacture Of Vaccine AdjuvantsNOVARTISJul 7, 2016
EP2396030
Influenza Vaccine Regimens For Pandemic-Associated StrainsNOVARTISMay 11, 2016
EP2268309
Improvements In Preparation Of Influenza Virus Vaccine AntigensNOVARTISOct 21, 2015
EP2457590
Protein FormulationARECORSep 24, 2015
EP2121011
Vaccines Including Antigen From Four Strains Of Influenza VirusNOVARTISFeb 20, 2015

Latest patents of Glaxosmithkline Biologicals S.a. opposed by its competitors

Explore Glaxosmithkline Biologicals S.a.'s recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP3527224
Feb 26, 2025Rsv Immunization Regimen1
EP4144368
Feb 26, 2025Rsv Immunization Regimen1
EP4226941
Oct 23, 2024Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna5
EP3480209
Nov 29, 2023Expression System1
EP4043040
Jan 11, 2023Small Liposomes For Delivery Of Immunogen-Encoding Rna5
EP4008357
Dec 28, 2022Small Liposomes For Delivery Of Immunogen-Encoding Rna5
EP4066855
Dec 28, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
EP4066857
Dec 21, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
EP4066856
Dec 7, 2022Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna4
EP4005592
Oct 12, 2022Virion-Like Delivery Particles For Self-Replicating Rna Molecules2

Latest PTAB cases involving Glaxosmithkline Biologicals S.a.

Discover the latest PTAB cases involving Glaxosmithkline Biologicals S.a., highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Glaxosmithkline Biologicals S.a. with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
GLAXOSMITHKLINE BIOLOGICALS SA2610029
PFIZER761174412
SANOFI7124 - -
WEICKMANN & WEICKMANN56 - - -